guluronic acid has been researched along with Inflammation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jafarzadeh, A; Mirshafiey, A; Mirzaei, MR; Mortazavi-Jahromi, SS; Taeb, M | 1 |
| Anissian, A; Enderami, SE; Hassannia, H; Hemmatzadeh, M; Hosseini, F; Jadidi-Niaragh, F; Kokhaei, P; Mahdian-Shakib, A; Mirshafiey, A; Mohammadi, H; Mohammed, HA | 1 |
| Cuzzocrea, S; Esposito, E; Mirshafiey, A; Mortazavi-Jahromi, SS; Taeb, M | 1 |
| Aghamohammadi, A; Aletaha, S; Asgardoon, MH; Asgary, V; Azizi, G; Bigdeli, R; Bokaie, S; Mirshafiey, A; Sharifi, L | 1 |
| Afraei, S; Hosseini, M; Jamshidi, AR; Khadem Azarian, S; Mahmoudi, M; Mirshafiey, A; Mostafaei, S; Nazeri, S; Vojdanian, M | 1 |
| Afraei, S; Azizi, G; Mirshafiey, A; Sedaghat, R; Zargar, SJ | 1 |
| Bretzel, RG; Entenmann, H; Federlin, K; Hannig, K; Horcher, A; Klöck, G; Kowalski, M; Sieber, U; Zekorn, T; Zimmermann, U | 1 |
1 trial(s) available for guluronic acid and Inflammation
| Article | Year |
|---|---|
The safety and efficacy of Guluronic acid (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Hexuronic Acids; Humans; Inflammation; Male; Naproxen; Spondylitis, Ankylosing; Treatment Outcome | 2019 |
6 other study(ies) available for guluronic acid and Inflammation
| Article | Year |
|---|---|
An in vitro evaluation of anti-aging effect of guluronic acid (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs.
Topics: Adult; Aging; Gene Expression; Granulocyte Colony-Stimulating Factor; Hexuronic Acids; Humans; Inflammation; Interleukin-3; Leukocytes, Mononuclear; Middle Aged; Nitric Oxide Synthase Type II; Oxidative Stress; Recombinant Fusion Proteins; RNA | 2017 |
Anti-inflammatory and anti-tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Female; Hexuronic Acids; Immunosuppression Therapy; Inflammation; Mammary Neoplasms, Animal; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Neoplasm Metastasis; Survival Analysis; Tumor Microenvironment | 2018 |
Evaluation of the Effect of α-L-Guluronic Acid (G2013) on COX-1, COX-2 Activity and Gene Expression for Introducing this Drug as a Novel NSAID with Immunomodulatory Property.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Female; Gene Expression Regulation; Hexuronic Acids; Humans; Immunologic Factors; Inflammation; Leukocytes, Mononuclear; Male; Middle Aged; RNA, Messenger; Uronic Acids | 2018 |
Antagonistic Property of G2013 (α-L-Guluronic Acid) on Gene Expression of MyD88, Tollip, and NF-κB in HEK293 TLR2 and HEK293 TLR4.
Topics: Cell Line; Dose-Response Relationship, Drug; Gene Expression; HEK293 Cells; Hexuronic Acids; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Myeloid Differentiation Factor 88; NF-kappa B; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA | 2019 |
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Encephalomyelitis, Autoimmune, Experimental; Female; Hexuronic Acids; Inflammation; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Uronic Acids | 2015 |
Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis.
Topics: Alginates; Animals; Dialysis; Electrophoresis; Fibrosis; Hexuronic Acids; Inflammation; Injections, Intraperitoneal; Mice; Microspheres; Mitogens; Rats; Uronic Acids | 1992 |